4.8 Article

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules

Matteo Stravalaci et al.

Summary: This study demonstrates that selected human humoral fluid-phase pattern recognition molecules can interact with SARS-CoV-2 in COVID-19, including PTX3 and MBL, exerting antiviral activity and being associated with disease severity. These findings have important implications for resistance and pathogenesis of COVID-19.

NATURE IMMUNOLOGY (2022)

Article Medicine, General & Internal

C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy

Xiaoqian Yang et al.

Summary: This study compared the diagnostic value and predictive effects of C4d between lupus nephritis (LN) and IgA nephropathy (IgAN) patients. The results showed that LN patients had a higher proportion of renal C4d deposition and a different distribution pattern compared to IgAN patients. Furthermore, renal C4d deposition was associated with disease relapse in LN patients and disease progression in IgAN patients.

FRONTIERS IN MEDICINE (2022)

Article Hematology

Complement dysregulation is associated with severe COVID-19 illness

Jia Yu et al.

Summary: The serum of COVID-19 patients can induce complement-mediated cell death and is associated with dysregulation of APC, which may contribute to the pathogenesis and severity of the disease.

HAEMATOLOGICA (2022)

Article Immunology

Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19

Abhigyan Satyam et al.

Summary: Lung inflammation and damage play a significant role in COVID-19 morbidity and mortality. The deposition of complement components in the lungs of COVID-19 patients suggests the activation of classical and alternative pathways, supporting the use of complement inhibitors as a potential treatment strategy.

CLINICAL IMMUNOLOGY (2021)

Article Immunology

Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease

Laura Bergamaschi et al.

Summary: The kinetics of immune changes in COVID-19 across different severity groups show that early bystander CD8(+) T cell immune response is prominent in asymptomatic or mild diseases, while severe cases have persistent cellular abnormalities and immune defects, which may increase clinical risks.

IMMUNITY (2021)

Article Medicine, General & Internal

Sutimlimab in Cold Agglutinin Disease

Alexander Roeth et al.

Summary: In patients with cold agglutinin disease, treatment with sutimlimab rapidly halted hemolysis, increased hemoglobin levels, and reduced fatigue by selectively inhibiting activity in the classic complement pathway.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Gyorgy Sinkovits et al.

Summary: Uncontrolled complement activation is associated with advanced disease severity of COVID-19, with patients more likely to die when accompanied by overactivation and consumption of C3. These findings support the potential use of complement inhibitory drugs in the treatment of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients

Ying Ding et al.

Summary: The study found that C4d deposition in renal tissues was common among patients with lupus nephritis (LN), with tubular basement membrane C4d deposition being associated with disease activity, and arteriolar C4d deposition being associated with renal microvascular lesions (RVLs) and worse renal outcomes.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins

Youssif M. Ali et al.

Summary: Early and persistent complement activation is crucial in the pathogenesis of COVID-19, leading to a series of pathological events that trigger severe inflammatory responses to SARS-CoV-2. Research targeting MASP-2 suggests that the LP pathway of the complement system could offer a therapeutic window for treating severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

COVID-19: Immunology and treatment options

Susanna Felsenstein et al.

CLINICAL IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Ophthalmology

Complement Activation Levels Are Related to Disease Stage in AMD

Thomas J. Heesterbeek et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)

Article Immunology

Complement Nomenclature - Deconvoluted

Suzanne S. Bohlson et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Medical Laboratory Technology

Preanalytical classical and alternative complement pathway activity loss

Koen O. A. Vercauteren et al.

BIOCHEMIA MEDICA (2019)

Review Immunology

Interpretation of Serological Complement Biomarkers in Disease

Kristina N. Ekdahl et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1

Nitai Roy et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)

Article Pathology

Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers

Shangbin Yang et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)

Review Biotechnology & Applied Microbiology

Complement, a target for therapy in inflammatory and degenerative diseases

B. Paul Morgan et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Review Immunology

Complement system part I - molecular mechanisms of activation and regulation

Nicolas S. Merle et al.

FRONTIERS IN IMMUNOLOGY (2015)

Review Biochemistry & Molecular Biology

An international serum standard for application in assays to detect human complement activation products

Grethe Bergseth et al.

MOLECULAR IMMUNOLOGY (2013)

Article Multidisciplinary Sciences

Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2

David Heja et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Pharmacology & Pharmacy

Complement in health and disease

Maria V. Carroll et al.

ADVANCED DRUG DELIVERY REVIEWS (2011)

Article Hematology

C1-Inhibitor: More Than a Serine Protease Inhibitor

Sacha Zeerleder

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)

Review Cell Biology

Complement and its role in innate and adaptive immune responses

Jason R. Dunkelberger et al.

CELL RESEARCH (2010)

Review Immunology

Complement: a key system for immune surveillance and homeostasis

Daniel Ricklin et al.

NATURE IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide

Lubka T. Roumenina et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)

Article Immunology

The clearance of apoptotic cells by complement

Roelof Flierman et al.

IMMUNOBIOLOGY (2007)

Article Immunology

Interaction of C1q and mannan-binding lectin with viruses

NM Thielens et al.

IMMUNOBIOLOGY (2002)

Article Biochemistry & Molecular Biology

Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and-2

V Rossi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Immunology

Continual low-level activation of the classical complement pathway

AP Manderson et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2001)